111 related articles for article (PubMed ID: 37393519)
1. Sanguinarine targets BRD4 to suppress cell proliferation and migration in clear cell renal cell carcinoma.
Wen Y; Song Y; Ma Y; Wen J; Yang J
J Biochem Mol Toxicol; 2023 Nov; 37(11):e23451. PubMed ID: 37393519
[TBL] [Abstract][Full Text] [Related]
2. The novel CDK9 inhibitor, XPW1, alone and in combination with BRD4 inhibitor JQ1, for the treatment of clear cell renal cell carcinoma.
Kuang Z; Guo K; Cao Y; Jiang M; Wang C; Wu Q; Hu G; Ao M; Huang M; Qin J; Zhao T; Lu S; Sun C; Li M; Wu T; Liu W; Fang M
Br J Cancer; 2023 Dec; 129(12):1915-1929. PubMed ID: 37884683
[TBL] [Abstract][Full Text] [Related]
3. Bromodomain-Containing Protein 4 (BRD4) Inhibition Sensitizes Palomid 529-Induced Anti-Renal Cell Carcinoma Cell Activity in Vitro and in Vivo.
Xing ZY; Wang Y; Cheng L; Chen J; He XZ; Xing W
Cell Physiol Biochem; 2018; 50(2):640-653. PubMed ID: 30308518
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of BRD4 Suppresses Cell Proliferation and Induces Apoptosis in Renal Cell Carcinoma.
Wu X; Liu D; Gao X; Xie F; Tao D; Xiao X; Wang L; Jiang G; Zeng F
Cell Physiol Biochem; 2017; 41(5):1947-1956. PubMed ID: 28391274
[TBL] [Abstract][Full Text] [Related]
5. Binding pocket-based design, synthesis and biological evaluation of novel selective BRD4-BD1 inhibitors.
Ma J; Chen H; Yang J; Yu Z; Huang P; Yang H; Zheng B; Liu R; Li Q; Hu G; Chen Z
Bioorg Med Chem; 2019 May; 27(9):1871-1881. PubMed ID: 30926312
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of BRD4 prevents proliferation and epithelial-mesenchymal transition in renal cell carcinoma via NLRP3 inflammasome-induced pyroptosis.
Tan YF; Wang M; Chen ZY; Wang L; Liu XH
Cell Death Dis; 2020 Apr; 11(4):239. PubMed ID: 32303673
[TBL] [Abstract][Full Text] [Related]
7. Discovery of the natural product 3',4',7,8-tetrahydroxyflavone as a novel and potent selective BRD4 bromodomain 2 inhibitor.
Li J; Zou W; Yu K; Liu B; Liang W; Wang L; Lu Y; Jiang Z; Wang A; Zhu J
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):903-913. PubMed ID: 33820450
[TBL] [Abstract][Full Text] [Related]
8. Case Report: 7-Ethyl-10-Hydroxycamptothecin, a DNA Topoisomerase I Inhibitor, Performs BRD4 Inhibitory Activity and Inhibits Human Leukemic Cell Growth.
Wang A; Li L; Li M; Wang S; Wang C
Front Pharmacol; 2021; 12():664176. PubMed ID: 33995089
[TBL] [Abstract][Full Text] [Related]
9. A 7-methoxybicoumarin derivative selectively inhibits BRD4 BD2 for anti-melanoma therapy.
Yang GJ; Wang W; Lei PM; Leung CH; Ma DL
Int J Biol Macromol; 2020 Dec; 164():3204-3220. PubMed ID: 32860796
[TBL] [Abstract][Full Text] [Related]
10. BRD4 inhibition suppresses cell growth, migration and invasion of salivary adenoid cystic carcinoma.
Wang L; Wu X; Wang R; Yang C; Li Z; Wang C; Zhang F; Yang P
Biol Res; 2017 May; 50(1):19. PubMed ID: 28545522
[TBL] [Abstract][Full Text] [Related]
11. Mir-144-3p Promotes Cell Proliferation, Metastasis, Sunitinib Resistance in Clear Cell Renal Cell Carcinoma by Downregulating ARID1A.
Xiao W; Lou N; Ruan H; Bao L; Xiong Z; Yuan C; Tong J; Xu G; Zhou Y; Qu Y; Hu W; Gao Y; Ru Z; Liu L; Xiao H; Chen K; Yang H; Zhang X
Cell Physiol Biochem; 2017; 43(6):2420-2433. PubMed ID: 29073615
[TBL] [Abstract][Full Text] [Related]
12. Apigenin suppresses proliferation, invasion, and epithelial-mesenchymal transition of cervical carcinoma cells by regulation of miR-152/BRD4 axis.
Zhao X; Zhou HB; Liu J; Xie J; Hu R
Kaohsiung J Med Sci; 2021 Jul; 37(7):583-593. PubMed ID: 33611824
[TBL] [Abstract][Full Text] [Related]
13. Sinomenine hydrochloride attenuates the proliferation, migration, invasiveness, angiogenesis and epithelial-mesenchymal transition of clear-cell renal cell carcinoma cells via targeting Smad in vitro.
Zhao B; Liu L; Mao J; Liu K; Fan W; Liu J; Zhang Z; Li Q
Biomed Pharmacother; 2017 Dec; 96():1036-1044. PubMed ID: 29198924
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of indole-2-one derivatives as potent BRD4 inhibitors.
Xu Y; Zhang XJ; Li WB; Wang XR; Wang S; Qiao XP; Chen SW
Eur J Med Chem; 2020 Dec; 208():112780. PubMed ID: 32883643
[TBL] [Abstract][Full Text] [Related]
15. PLEK2 promotes the proliferation and migration of non-small cell lung cancer cells in a BRD4-dependent manner.
Cai T; Yao W; Qiu L; Zhu AR; Shi Z; Du Y
Mol Biol Rep; 2022 May; 49(5):3693-3704. PubMed ID: 35122599
[TBL] [Abstract][Full Text] [Related]
16. SH3BGRL2 inhibits growth and metastasis in clear cell renal cell carcinoma via activating hippo/TEAD1-Twist1 pathway.
Yin L; Li W; Xu A; Shi H; Wang K; Yang H; Wang R; Peng B
EBioMedicine; 2020 Jan; 51():102596. PubMed ID: 31911271
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of novel 4,4-difluoro-1-methyl-N, 6-diphenyl-5, 6-dihydro-4H-pyrimido [4, 5-b] [1, 2, 4] triazolo [4, 3-d] [1, 4] diazepin-8-amine derivatives as potential BRD4 inhibitors.
Li J; Zhang W; Qiu Q; Zhou D; Feng Z; Tong Z; Wei J; Huang W; Li J; Qian H; Shi W
Chem Biol Drug Des; 2021 May; 97(5):1117-1128. PubMed ID: 33638254
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of benzo[cd]indol-2(1H)-ones derivatives as BRD4 inhibitors.
Feng Y; Xiao S; Chen Y; Jiang H; Liu N; Luo C; Chen S; Chen H
Eur J Med Chem; 2018 May; 152():264-273. PubMed ID: 29730189
[TBL] [Abstract][Full Text] [Related]
19. Discovery and characterization of bromodomain 2-specific inhibitors of BRDT.
Yu Z; Ku AF; Anglin JL; Sharma R; Ucisik MN; Faver JC; Li F; Nyshadham P; Simmons N; Sharma KL; Nagarajan S; Riehle K; Kaur G; Sankaran B; Storl-Desmond M; Palmer SS; Young DW; Kim C; Matzuk MM
Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33637650
[TBL] [Abstract][Full Text] [Related]
20. The BD2 domain of BRD4 is a determinant in EndoMT and vein graft neointima formation.
Zhang M; Wang B; Urabe G; Huang Y; Plutzky J; Kent KC; Guo LW
Cell Signal; 2019 Sep; 61():20-29. PubMed ID: 31075399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]